Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy.

Wang, Shan; Fu, Jia-Lei; Hao, Hui-Feng; Jiao, Yan-Na; Li, Ping-Ping; Han, Shu-Yan

Wang, Shan; Fu, Jia-Lei; Hao, Hui-Feng; Jiao, Yan-Na; Li, Ping-Ping; Han, Shu-Yan.

Afiliación

Wang S; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China.
Fu JL; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China.
Hao HF; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China.
Jiao YN; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China.
Li PP; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China. Electronic address: lppma123@163.com.
Han SY; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Integration of Chinese and Western Medicine, Peking University Cancer Hospital and Institute, Beijing 100142, PR China. Electronic address: shuyanhan@bjmu.edu.cn.

Pharmacol Res ; 170: 105728, 2021 08.

Article en En | MEDLINE | ID: mdl-34119622

Asunto(s)

Antineoplásicos Fitogénicos/uso terapéutico; Medicamentos Herbarios Chinos/uso terapéutico; Metabolismo Energético/efectos de los fármacos; Medicina Tradicional China; Neoplasias/tratamiento farmacológico; Animales; Antineoplásicos Fitogénicos/efectos adversos; Medicamentos Herbarios Chinos/efectos adversos; Humanos; Neoplasias/metabolismo; Neoplasias/patología

Palabras clave

Amino acid metabolism; Astragalus polysaccharide (PubChem CID: 2782115); Atractylenolide I (PubChem CID: 5321018); Berberine (PubChem CID: 2353); Brutieridin (PubChem CID: 101485561); Bufalin (PubChem CID: 9547215); Cancer cell metabolic reprogramming; Carnosic acid (PubChem CID: 65126); Celastrol (PubChem CID: 122724); Chlorogenic acid (PubChem CID: 1794427); Chrysin (PubChem CID: 5281607); DT-13 (PubChem CID: 101514160); Desmethoxycurcumin (PubChem CID: 5469424); Dioscin (PubChem CID: 119245); Emodin (PubChem CID: 3200); Euxanthone (PubChem CID: 5281631); Glycolysis; L42 (PubChem CID: 5288052); Licochalcone A (PubChem CID: 5318998); Lipid metabolism; MAP30 (PubChem CID: 451600); Matrine (PubChem CID: 91466); Melitidin (PubChem CID: 101485562); Melittin (PubChem CID: 16133648); Oleanolic acid (PubChem CID: 10494); Oridonin (PubChem CID: 5321010); Osthole (PubChem CID: 10228); Physapubescin I (PubChem CID: 132529929); Polyphyllin â¥ (PubChem CID: 10417550); Protopanaxadiol (PubChem CID: 9920281); Quercetin (PubChem CID: 5280343); Resibufogenin (PubChem CID: 6917974); Rhein (PubChem CID: 10168); Scutellarin (PubChem CID: 185617) Astragaloside IV (PubChem CID: 13943297); Shikonin (PubChem CID: 479503); Tanshinone IIA (PubChem CID: 164676); Tetrandrine (PubChem CID: 73708); Traditional Chinese medicine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Medicamentos Herbarios Chinos / Metabolismo Energético / Medicina Tradicional China / Neoplasias / Antineoplásicos Fitogénicos Tipo de estudio: Diagnostic_studies Límite: Animals / Humans Idioma: En Revista: Pharmacol Res Asunto de la revista: FARMACOLOGIA Año: 2021 Tipo del documento: Article Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google